Abstract:In this study, we present the synthesis, characterization and in vitro cytotoxicity of six organometallic [Ru(II)(η6-p-cymene)(N,N)Cl]Cl, [Rh(III)(η5-C5Me5)(N,N)Cl]Cl and [Re(I)(CO)3(N,N)Cl] complexes, in which the (N,N) ligands are sterane-based 2,2'-bipyridine derivatives (4-Me-bpy-St-OH, 4-Ph-bpy-St-OH). The solution chemical behavior of the ligands and the complexes was explored by UV-visible spectrophotometry and 1H NMR spectroscopy. The ligands and their Re(I) complexes are neutral at pH = 7.40 contributing to their highly lipophilic character (logD7.40 > +3). Whereas, the Ru(II) and Rh(III) half-sandwich complexes are much more hydrophilic, which property is greatly affected by the actual chloride ion content of the medium. The half-sandwich Ru and Rh complexes are highly stable in 30% (v/v) DMSO/water (< 5% dissociation at pH = 7.40), which is further increased in water. The Rh(III)(η5-C5Me5) complexes were characterized by higher water/chloride exchange and pKa constants compared to the Ru(II)(η6-p-cymene) counterparts. The Re(I)(CO)3 complexes are also stable in solution in a wide pH range (2 – 12) without the release of the bidentate ligand, only the chlorido co-ligand can be replaced by OH– at higher pH values. A comprehensive discussion of the binding affinity of the half-sandwich Ru(II) and Rh(III) complexes toward human serum albumin and calf-thymus DNA is also provided. The Ru(II)(η6-p-cymene) complexes interact with human serum albumin via intermolecular forces, while for the Rh(III)(η5-C5Me5) complexes coordinative binding mode was suggested as well. They are also able to interact with calf-thymus DNA most likely via the coordination of guanine nitrogen. The Ru(II)(η6-p-cymene) complexes were found to be the most promising among the tested compounds as they exhibited moderate-to-strong cytotoxic activity (IC50 = 3 – 11 μM) in LNCaP as well as in PC3 prostate cells in an androgen receptor-independent manner. They were also significantly cytotoxic in breast and colon adenocarcinoma cancer cell lines and showed good selectivity for cancer cells.

New Ru(II)- p -cymene compounds bearing indomethacin and indomethacin-pyridineamide ligands: Synthesis, characterization, computational studies and investigation of their interactions with the human serum albumin

Design of Ru(II)-NHC-Diamine Precatalysts Directed by Ligand Cooperation: Applications and Mechanistic Investigations for Asymmetric Hydrogenation

Investigation of enzyme and serum protein protective effects, along with molecular docking studies of mixed ligand ruthenium(II) polypyridyl complexes

Ru(II)‐Nitrophenylhydrazine/Chlorophenylhydrazine Complexes: Nanoarchitectonics, Biological Evaluation and In silico Study

Organometallic Ru(II), Rh(III) and Re(I) complexes of sterane-based bidentate ligands: Synthesis, solution speciation, interaction with biomolecules and anticancer activity

In vitro interaction investigation between three Ru(II) arene complexes and human serum albumin: structural influences

Fortuitous synthesis of unsaturated half-sandwich Ruthenium(II) complexes via solvent-involved rearrangement and their biological evaluation

Synthesis, Cytotoxicity, and Biomacromolecule Binding: Three Isomers of Nitrosylruthenium Complexes with Bidentate Bioactive Molecules As Co-Ligands

Investigation of half-sandwich platinum group metal complexes featuring benzamide derived ligands and their diazido derivatives: Synthesis, molecular structures and biological studies

Exploring the potential of highly charged Ru(II)- and heteronuclear Ru(II)/Cu(II)-polypyridyl complexes as antimicrobial agents

Sonochemical Effect on Two New Ruthenium(Ii) Complexes with Ligand (E)-N-((6-bromopyridin-2-yl)methylene)-4-(methylthio)aniline Precursors for Synthesis of Ruo2 Nanoparticles

Syntheses and Evaluation of Drug-Like Properties of Co-Releasing Molecules Containing Ruthenium and Group 6 Metal

Anti-amyloid aggregation and anti-hyperglycemic activities of novel ruthenium uracil Schiff base compounds

Water‐soluble μ‐oxo triruthenium compound of biological interest: H‐bonds network and interaction with HSA

Exploring Ruthenium-based organometallic inhibitors against Plasmodium Calcium Dependent Kinase 2 (PfCDPK2): a combined ensemble docking, QM paramterization and molecular dynamics study

Synthesis and antimicrobial activity of new pyridine-based half-sandwich Ru(II) complexes

Comparative Investigation of Interactions Between Two Ruthenium(ii) Arene PTA Type Complexes with Curcuminoid Ligands and Human Serum Albumin

Bioactive ruthenium(II)-arene complexes containing modified 18β-glycyrrhetinic acid ligands.

Novel Ruthenium Complexes Ligated with 4-Anilinoquinazoline Derivatives: Synthesis, Characterisation and Preliminary Evaluation of Biological Activity.

Novel half-sandwich ruthenium(II) nicotinic hydrazone complexes: An efficient class of catalyst for the N-alkylation of amines with benzyl alcohol via transfer hydrogen mechanism and effective antibacterial agents

N‐heterocyclic carbene complexes RuII(arene) and their application as ROMP catalysts, antioxidant and anticancer agents